Fate Therapeutics Inc. Company Profile
NASDAQ: FATEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.15-0.14 (-6.11%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Fate Therapeutics at a glance
Fate Therapeutics Inc. (NASDAQ: FATE) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2013. At a market capitalization of $257.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001434316, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Fate Therapeutics Inc.
- Ticker
- NASDAQ: FATE
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2013
- Market cap
- $257.61M
- SEC CIK
- 0001434316
Companies similar to Fate Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PALIPalisade Bio Inc. | 1.48 | -0.67% | $257.92M | vs FATE |
| SABSSAB Biotherapeutics Inc. | 2.88 | -1.71% | $262.04M | vs FATE |
| IKTInhibikase Therapeutics Inc. | 1.94 | -2.02% | $270.70M | vs FATE |
| LXEOLexeo Therapeutics Inc. | 3.31 | +0.30% | $271.71M | vs FATE |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs FATE |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs FATE |
| XFORX4 Pharmaceuticals Inc. | 2.81 | +1.44% | $278.60M | vs FATE |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs FATE |